These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15934953)

  • 21. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H; Iijima M; Chaki S
    Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
    McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
    J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glial inhibitors influence the mRNA and protein levels of mGlu2/3, 5 and 7 receptors and potentiate the analgesic effects of their ligands in a mouse model of neuropathic pain.
    Osikowicz M; Skup M; Mika J; Makuch W; Czarkowska-Bauch J; Przewlocka B
    Pain; 2009 Dec; 147(1-3):175-86. PubMed ID: 19782473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of c-Fos induction in the brain by the mGlu2/3 receptor antagonist LY341495 and agonist LY354740: evidence for widespread endogenous tone at brain mGlu2/3 receptors in vivo.
    Linden AM; Bergeron M; Schoepp DD
    Neuropharmacology; 2005; 49 Suppl 1():120-34. PubMed ID: 16023151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HDAC and HAT inhibitors differently affect analgesia mediated by group II metabotropic glutamate receptors.
    Zammataro M; Sortino MA; Parenti C; Gereau RW; Chiechio S
    Mol Pain; 2014 Nov; 10():68. PubMed ID: 25406541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.
    Okamura N; Hashimoto K; Shimizu E; Koike K; Ohgake S; Koizumi H; Kumakiri C; Komatsu N; Iyo M
    Brain Res; 2003 Nov; 992(1):114-9. PubMed ID: 14604779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H; Fukumoto K; Iijima M; Chaki S
    Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats.
    Liechti ME; Markou A
    Eur J Pharmacol; 2007 Jan; 554(2-3):164-74. PubMed ID: 17113075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
    Hikichi H; Kaku A; Karasawa J; Chaki S
    J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist: investigations into possible mechanism of action in vivo.
    Bond A; Jones NM; Hicks CA; Whiffin GM; Ward MA; O'Neill MF; Kingston AE; Monn JA; Ornstein PL; Schoepp DD; Lodge D; O'Neill MJ
    J Pharmacol Exp Ther; 2000 Sep; 294(3):800-9. PubMed ID: 10945827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.
    Amitai N; Markou A
    Eur J Pharmacol; 2010 Aug; 639(1-3):67-80. PubMed ID: 20371228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice.
    Iijima M; Shimazaki T; Ito A; Chaki S
    Psychopharmacology (Berl); 2007 Feb; 190(2):233-9. PubMed ID: 17102982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic imipramine treatment reduces inhibitory properties of group II mGlu receptors without affecting their density or affinity.
    Pałucha A; Brański P; Kĺak K; Sowa M
    Pharmacol Rep; 2007; 59(5):525-30. PubMed ID: 18048952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent.
    Higgins GA; Ballard TM; Kew JN; Richards JG; Kemp JA; Adam G; Woltering T; Nakanishi S; Mutel V
    Neuropharmacology; 2004 Jun; 46(7):907-17. PubMed ID: 15081787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.
    Pałucha A; Brański P; Tokarski K; Bijak M; Pilc A
    Pol J Pharmacol; 1997; 49(6):495-7. PubMed ID: 9566055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [3H]-LY341495 as a novel antagonist radioligand for group II metabotropic glutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells.
    Johnson BG; Wright RA; Arnold MB; Wheeler WJ; Ornstein PL; Schoepp DD
    Neuropharmacology; 1999 Oct; 38(10):1519-29. PubMed ID: 10530814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological blockade of group II metabotropic glutamate receptors reduces the growth of glioma cells in vivo.
    Arcella A; Carpinelli G; Battaglia G; D'Onofrio M; Santoro F; Ngomba RT; Bruno V; Casolini P; Giangaspero F; Nicoletti F
    Neuro Oncol; 2005 Jul; 7(3):236-45. PubMed ID: 16053698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of mGlu3 receptors stimulates the production of GDNF in striatal neurons.
    Battaglia G; Molinaro G; Riozzi B; Storto M; Busceti CL; Spinsanti P; Bucci D; Di Liberto V; Mudò G; Corti C; Corsi M; Nicoletti F; Belluardo N; Bruno V
    PLoS One; 2009 Aug; 4(8):e6591. PubMed ID: 19672295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex.
    Zhai Y; George CA; Zhai J; Nisenbaum ES; Johnson MP; Nisenbaum LK
    Neuropsychopharmacology; 2003 Jan; 28(1):45-52. PubMed ID: 12496939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.